One in every 10 people worldwide is impacted by a rare genetic disease but about 50% of them remain undiagnosed despite rapid ...

Children's Mercy Kansas City has achieved a significant advancement toward the treatment of rare genetic diseases through the ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Dyne Therapeutics is a clinical stage biotech concern with just over $700 million of cash on its balance sheet. Learn more ...

Initial data from the BEACON study supported the potential for meaningful clinical differentiation of BEAM-101 as compared to currently available treatments for SCD. The data showed that treatment ...

A research team performed a large-scale genome analysis of Japanese and European populations and discovered gene regions (genetic polymorphisms) related to allergic sensitization. Some of these ...

Children born in spring or summer with a specific gene variant may have a higher risk of celiac disease and lower levels of a key protein, according to a study, potentially helping future research on ...

The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...

But the 72-year-old Mendoza, who has not been diagnosed with Alzheimer’s, isn’t getting the exam at a doctor’s office or a clinical lab. She’s in a comfortable and familiar place, sipping Cuban coffee ...

Explore the hidden dynamics of heart disease, its risks, and how new strategies and innovations help improve heart health ...

The last duck farm on New York's Long Island is facing an uncertain future after a bird flu outbreak forced the cullin ...

The case was a tricky one, a surgery was inevitable. The patient had lost a lot of blood. He was also in severe pain. Then, ...